FY2025 · ended Dec 31, 2025 · Revenue $796.85M, +0.6% YoY · Filed Feb 26, 2026
GoodRx Holdings, Inc. (GDRX) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $796.9 million and net income of $30.4 million. Free cash flow was $164.4 million. As of Jun 30, 2026 it held $296.1 million in cash and investments and $539.0 million in total debt.
Revenue (TTM)
$785.23M
-1.8% vs year-ago TTM
Net income (TTM)
$16.25M
-53.0% vs year-ago TTM
Operating cash flow (TTM)
$201.58M
+5.8% vs year-ago TTM
Free cash flow (TTM)
$197.09M
+4.0% vs year-ago TTM
EPS (TTM)
$0.05
-48.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
—
Net cash
$-242.84M
as of Jun 30, 2026
Operating margin
9.5%
FY 2026
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- GDRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Santa Monica, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1809519
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $796.9M | $792.3M | $750.3M | $766.6M | $745.4M |
| Operating income | $87.5M | $65.8M | -$27.0M | $1.7M | $13.4M |
| Net income | $30.4M | $16.4M | -$8.9M | -$32.8M | -$25.3M |
| Diluted EPS | $0.09 | $0.04 | -$0.02 | -$0.08 | -$0.06 |
| Operating cash flow | $167.9M | $183.9M | $138.3M | $146.8M | $178.8M |
| Free cash flow | $164.4M | $182.7M | $137.2M | $142.8M | $174.2M |
| Total assets | $1.4B | $1.4B | $1.6B | $1.6B | $1.6B |
| Total liabilities | $787.8M | $663.4M | $826.8M | $789.8M | $775.9M |
| Stockholders' equity | $616.3M | $724.7M | $762.0M | $814.8M | $831.7M |
| Cash and investments | $261.8M | $448.3M | $672.3M | $757.2M | $941.1M |
| Total debt | $549.5M | $551.7M | $711.1M | $725.3M | $713.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Restatement
|
Nov 2, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 583 GoodRx Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.